Longevity Health Holdings, Inc. Increase (Decrease) in Accounts Receivable
Longevity Health Holdings, Inc. (XAGE) reported Increase (Decrease) in Accounts Receivable of -$16.95 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-14
- Longevity Health Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$29.12K.
- Longevity Health Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $12.16K, a 13.74% decline year-over-year.
- Longevity Health Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$10.02K.
- Longevity Health Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$7.97K.
- Longevity Health Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$44.15K, a 1177.91% decline from fiscal 2024.
- Longevity Health Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $4.10K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$29.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$16.95K 10-Q · filed 2026-08-14 | -$26.98K derived: sum of 3 quarters · filed 2026-08-14 | -$34.95K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $12.16K 10-Q · filed 2026-05-15 | $2.14K derived: sum of 2 quarters · filed 2026-05-15 | -$5.83K derived: sum of 3 quarters · filed 2026-05-15 | -$46.09K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$10.02K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$18.00K derived: sum of 2 quarters · filed 2026-03-31 | -$58.25K derived: sum of 3 quarters · filed 2026-08-14 | -$44.15K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$7.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$48.23K derived: sum of 2 quarters · filed 2026-08-14 | -$34.13K 10-Q · filed 2025-11-14 | -$45.11K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$40.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$26.16K 10-Q · filed 2026-08-14 | -$37.14K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2025-03-31 | $14.10K 10-Q · filed 2026-05-15 | $3.12K derived: sum of 2 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$10.98K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.10K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $15.08K 10-Q · filed 2025-11-14 | |||
| 2023-09-30 | -$3.89M 10-Q · filed 2023-11-15 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |